Viewing Study NCT04482569


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-03-09 @ 7:03 AM
Study NCT ID: NCT04482569
Status: COMPLETED
Last Update Posted: 2023-02-16
First Post: 2020-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin
Sponsor: Evopoint Biosciences Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module